Literature DB >> 17917022

Blood and marrow transplantation: a perspective from the University of Minnesota.

John H Kersey1.   

Abstract

On the occasion of the first meeting of the Robert A. Good Immunology Society in June of 2006, I was asked to provide a perspective on the history and progress of the field of bone marrow transplantation. I was honored to provide this perspective at that meeting and subsequently in this manuscript. This review has a strong University of Minnesota bias, as Minneapolis is a place where important roots in this field were developed. Minnesota is also where I have spent my career in this field learning the excitement of laboratory research beginning as a medical student under Bob Good and Carlos Martinez in 1960, and clinical research in pediatrics under Bill Krivit and Mark Nesbit beginning in 1970. This review is dedicated to two of my recently deceased mentors: Bob Good was a pioneer in so many ways and a true giant in immunology and blood and marrow transplantation. Bill Krivit taught me a great deal about genetic diseases and the critical role of compassion and understanding patients and their families in dealing with fatal illness and new treatments such as bone marrow transplantation that are often risky and themselves may result in suffering and death. My affection for Bob Good and Bill Krivit is unending.

Entities:  

Mesh:

Year:  2007        PMID: 17917022     DOI: 10.1007/s12026-007-0037-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  71 in total

1.  [Iso-leuko-antibodies].

Authors:  J DAUSSET
Journal:  Acta Haematol       Date:  1958 Jul-Oct       Impact factor: 2.195

2.  Cytological identification of radiation-chimaeras.

Authors:  C E FORD; J L HAMERTON; D W BARNES; J F LOUTIT
Journal:  Nature       Date:  1956-03-10       Impact factor: 49.962

Review 3.  A historical review of bone marrow transplantation for immunodeficiencies.

Authors:  Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

4.  Transient graft-versus-host reaction in the treatment of leukemia in mice.

Authors:  M Boranić
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

5.  Radiobiological basis of total body irradiation with different dose rate and fractionation: repair capacity of hemopoietic cells.

Authors:  C W Song; T H Kim; F M Khan; J H Kersey; S H Levitt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-12       Impact factor: 7.038

6.  Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis.

Authors:  J L Naiman; H H Punnett; H W Lischner; M L Destiné; J B Arey
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

7.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

8.  Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.

Authors:  E Gluckman; G Socie; A Devergie; H Bourdeau-Esperou; R Traineau; J M Cosset
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

9.  Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation.

Authors:  W Krivit; M E Pierpont; K Ayaz; M Tsai; N K Ramsay; J H Kersey; S Weisdorf; R Sibley; D Snover; M M McGovern
Journal:  N Engl J Med       Date:  1984-12-20       Impact factor: 91.245

10.  Sclerodermatous graft-versus-host disease limited to an area of measles exanthem.

Authors:  J R Fenyk; C M Smith; P I Warkentin; W Krivit; R W Goltz; J E Neely; M E Nesbit; N K Ramsay; P F Coccia; J H Kersey
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.